Q1 2025 Earnings Call Transcript April 30, 2025 Guardant Health, Inc. beats earnings expectations. Reported EPS is $-0.49, ...

Fulcrum Therapeutics, Inc. ( NASDAQ: FULC) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET Alex Sapir – President and Chief Executive Officer Alan Musso – Chief Financial Officer Iain Fraser – ...

China is pivotal in the U.S. home goods market with more than a quarter of the sector's imports. This reliance underscores ...

US President Donald Trump’s administration plans to rescind the previous administration’s artificial intelligence (AI) chip ...

The global cervical dysplasia treatment market is on a trajectory of steady expansion, with projections indicating a rise from USD 628.5 million in 2023 to USD 846.2 million by 2033. This growth, at a ...

Request To Download Free Sample of This Strategic Report @ Rise in awareness regarding virtual training and simulation positively drives the virtual training and simulation market growth. This ...

Noodles & Company (NASDAQ: NDLS) Q1 2025 Earnings Call Transcript May 7, 2025 Noodles & Company misses on earnings ...

Q1 2025 Earnings Call Transcript April 29, 2025 Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0 ...

Dual chamber prefilled syringes market is estimated to be valued at $ 184.7 Mn in 2025, and is expected to reach $ 306.6 Mn by 2032, exhibiting a CAGR of 7.5%. BURLINGAME, CA, UNI ...

Nautilus Biotechnology, Inc. ( NASDAQ: NAUT) Q1 2025 Earnings Conference Call April 29, 2025 8:30 AM ET Ji-Yon Yi - Head, Investor Relations Sujal Patel - Co-Founder & Chief Executive Officer Parag ...

Nautilus will host a conference call to discuss the first quarter 2025 financial results, business developments and outlook before market open on Tuesday, April 29, 2025, at 5:30 AM Pacific Time / ...